Galmed Pharmaceuticals Ltd Working Capital to Net Assets Ratio
Galmed Pharmaceuticals Ltd working capital to net assets ratio. Galmed Pharmaceuticals Ltd (GLMD) has a Working Capital to Net Assets ratio of 69.9% as of June 2026. Working capital of $8.90 Million (current assets of $11.71 Million minus current liabilities of $2.81 Million) is measured against net assets of $12.74 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check GLMD tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Galmed Pharmaceuticals Ltd (2012–2025)
Working capital to net assets ratio of Galmed Pharmaceuticals Ltd from 2012 to 2025. This chart shows how Galmed Pharmaceuticals Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 69.9%, reflecting working capital of $8.90 Million against net assets of $12.74 Million USD. See Galmed Pharmaceuticals Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Galmed Pharmaceuticals Ltd Working Capital to Net Assets Ratio by Year (2012–2025)
Galmed Pharmaceuticals Ltd working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Galmed Pharmaceuticals Ltd from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Galmed Pharmaceuticals Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | $15.78 Million | $15.78 Million | $18.63 Million | $2.85 Million | ▲ +14.6 pp |
| 2024 | 85.4% | $13.95 Million | $16.33 Million | $16.12 Million | $2.17 Million | ▲ +9.9 pp |
| 2023 | 75.6% | $10.49 Million | $13.88 Million | $13.24 Million | $2.75 Million | ▼ -11.1 pp |
| 2022 | 86.6% | $11.63 Million | $13.42 Million | $14.72 Million | $3.09 Million | ▼ -12.3 pp |
| 2021 | 98.9% | $30.18 Million | $30.50 Million | $36.05 Million | $5.88 Million | ▼ -0.3 pp |
| 2020 | 99.2% | $43.80 Million | $44.15 Million | $51.81 Million | $8.01 Million | ▼ -0.3 pp |
| 2019 | 99.5% | $69.50 Million | $69.85 Million | $76.43 Million | $6.93 Million | ▼ -0.3 pp |
| 2018 | 99.8% | $87.70 Million | $87.89 Million | $90.41 Million | $2.71 Million | ▲ +2.9 pp |
| 2017 | 96.9% | $15.30 Million | $15.79 Million | $19.15 Million | $3.85 Million | ▼ -3.8 pp |
| 2016 | 100.7% | $11.15 Million | $11.07 Million | $15.73 Million | $4.58 Million | ▲ +4.0 pp |
| 2015 | 96.7% | $20.84 Million | $21.55 Million | $23.38 Million | $2.54 Million | ▼ -2.1 pp |
| 2014 | 98.8% | $31.03 Million | $31.41 Million | $32.15 Million | $1.12 Million | ▲ +20.1 pp |
| 2013 | 78.7% | $-1.54 Million | $-1.95 Million | $153.00K | $1.69 Million | ▲ +89.8 pp |
| 2012 | -11.1% | $219.00K | $-1.98 Million | $732.00K | $513.00K | — |